- |||||||||| Enrollment open, Trial initiation date: ESPRO2: NMES During the Day and Prior to Sleep (clinicaltrials.gov) - Mar 24, 2015
P=N/A, N=12, Recruiting, Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Jan 2015
- |||||||||| Enrollment change, Combination therapy: Effect of Immunocal (clinicaltrials.gov) - Jan 22, 2015
P2, N=99, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Apr 2015 N=80 --> 99
- |||||||||| Trial completion, Trial primary completion date: Muscle Mass and Function in Chinese Adults (clinicaltrials.gov) - Jan 20, 2015
P=N/A, N=412, Completed, Not yet recruiting --> Recruiting Not yet recruiting --> Completed | Trial primary completion date: Feb 2015 --> Oct 2014
- |||||||||| tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Trial termination: Insulin and Sarcopenia in the Elderly (clinicaltrials.gov) - Jan 17, 2015 P=N/A, N=88, Terminated, Not yet recruiting --> Completed | Trial primary completion date: Feb 2015 --> Oct 2014 Recruiting --> Terminated
- |||||||||| Enrollment closed, Trial primary completion date: Nutrition and Exercise for Sarcopenia (clinicaltrials.gov) - Jan 17, 2015
P=N/A, N=108, Active, not recruiting, Initiation date: May 2014 --> Mar 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Dec 2014
- |||||||||| Trial initiation date, Trial primary completion date: Cardiorespiratory Training and Ventilatory Muscle Strength (clinicaltrials.gov) - Jan 6, 2015
P=N/A, N=30, Not yet recruiting, Trial primary completion date: Dec 2014 --> Jul 2015 Initiation date: Jan 2014 --> Jul 2015 | Trial primary completion date: Dec 2014 --> Jun 2016
- |||||||||| Delatestryl (testosterone enanthate) / Endo
Trial completion: 5-Alpha Reductase and Anabolic Effects of Testosterone (clinicaltrials.gov) - Dec 24, 2014 P2, N=60, Completed, Not yet recruiting --> Completed | Trial primary completion date: Oct 2012 --> Jan 2013 Active, not recruiting --> Completed
- |||||||||| Trial primary completion date: Calorie Restriction With Leucine Supplementation (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=75, Recruiting, Trial primary completion date: Dec 2017 --> Dec 2016 Trial primary completion date: Dec 2014 --> Jul 2015
- |||||||||| omega-3 ethylester concentrate / Generic mfg.
Trial completion: Fish Oil and Muscle Function (clinicaltrials.gov) - Dec 10, 2014 P=N/A, N=77, Completed, Trial primary completion date: Dec 2014 --> Jul 2015 Recruiting --> Completed
- |||||||||| allopurinol / Generic mfg.
Enrollment change, Trial initiation date, Trial primary completion date: Allopurinol in Functional Impairment (ALFIE) Trial: 'Improving Muscle Strength' (clinicaltrials.gov) - Nov 12, 2014 P4, N=124, Enrolling by invitation, Recruiting --> Completed | Phase classification: P2 --> PN/A N=70 --> 124 | Initiation date: Aug 2014 --> Dec 2014 | Trial primary completion date: Apr 2017 --> Aug 2017
- |||||||||| Enrollment open: Omega-3 Fatty Acids to Combat Sarcopenia (clinicaltrials.gov) - Nov 12, 2014
P=N/A, N=24, Recruiting, N=70 --> 124 | Initiation date: Aug 2014 --> Dec 2014 | Trial primary completion date: Apr 2017 --> Aug 2017 Not yet recruiting --> Recruiting
|